SCHEMBL9370600

SCHEMBL9370600

CC(OCn1cnc(-c2ccccc2)c1-c1ccccc1)[Si](C)(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.50
PRKD3 O94806 1/20 0.44
MAP4K4 O95819 1/20 0.44
FRK P42685 1/20 0.44
MAPK9 P45984 1/20 0.44
CSNK1A1 P48729 1/20 0.44
CSNK1D P48730 1/20 0.44
GSK3B P49841 1/20 0.44
PRKD2 Q9BZL6 1/20 0.44
MAP4K5 Q9Y4K4 1/20 0.44
LMNA P02545 3/20 0.43
NSD3 Q9BZ95 1/20 0.41
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27980049 0.76 PTGS2 (0.58) PTGS2PRKD3MAP4K4FRKMAPK9
SCHEMBL7475809 0.75 TDP1 (0.53) LMNATSHRAPAF1HTTMAPT
SCHEMBL4064723 0.75 PTGS2 (0.50) PTGS2PRKD3MAP4K4FRKMAPK9
SCHEMBL4805174 0.74 PTGS2 (0.63) PTGS2PRKD3MAP4K4FRKMAPK9
SCHEMBL11424185 0.72 PTGS2 (0.54) PTGS2PRKD3MAP4K4FRKMAPK9
SCHEMBL9370596 0.72 LMNA (0.43) PTGS2PRKD3MAP4K4FRKMAPK9
SCHEMBL10615042 0.71 PTGS2 (0.59) PTGS2PRKD3MAP4K4FRKMAPK9
SCHEMBL9525213 0.71 ALDH1A1 (0.44) PTGS2LMNAMAPK13MAPK12MAPK11
SCHEMBL3836933 0.71 PTGS2 (0.55) PTGS2PRKD3MAP4K4FRKMAPK9
SCHEMBL20466312 0.71 MAPK14 (0.60) PTGS2PRKD3MAP4K4FRKMAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5318984-A Anticholesterol agents which inhibit acetyl coenzyme A transferase THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-06-07 US disclosed
EP-0372445-B1 Imidazoles for the treatment of atherosclerosis DU PONT MERCK PHARMA (US) 1994-03-09 EP disclosed
US-5166214-A Enzyme inhibitors for anticholesterol agents, enzyme inhibitor and cardiovascular disorders DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-11-24 US disclosed
EP-0372445-A1 Imidazoles for the treatment of atherosclerosis THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1990-06-13 EP disclosed